Health Products

One lot of Verkazia (cyclosporine) eye drops recalled due to potential presence of particulate matter

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products
Product: Verkazia (cyclosporine) eye drops (DIN 02484137, lot 1N81H)
Issue: Health products - Product safety
What to do: If you see particulate matter (e.g. crystal-like particles) in the vials or if your eye symptoms worsen, stop using the product and consult your pharmacist to obtain a replacement as soon as possible. Consult a health care professional if you have used this product and have health concerns.
Audience: General public
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Products

Manufacturer / Canadian ImporterDINProductLotExpiry
Santen Inc. / McKesson Specialized Distribution02484137Verkazia (cyclosporine) eye drops1N81H02/2023

Issue

McKesson Specialized Distribution (MSD) is recalling one lot (1N81H) of Verkazia (cyclosporine) eye drops after certain vials from the lot were found to contain particulate matter. The manufacturer, Santen Inc., determined the particles were a crystalized form of the active drug ingredient, cyclosporine. The particulate matter may irritate the surface of the eye. Solidified cyclosporine may also reduce the concentration of the drug in the solution, which may reduce the treatment’s effectiveness.

MSD, the Canadian importer, also recalled one lot (1N80H) of Verkazia in August 2021 due to the potential presence of particulate matter, which was identified during routine testing. Santen Inc. continues to investigate the cause of this issue and will report its findings to Health Canada.

Verkazia is a prescription drug used in children and adolescents from 4 to 18 years of age to treat a severe form of eye allergy called “vernal keratoconjunctivitis.”

Health Canada is monitoring MSD’s recall. If additional safety information is identified, Health Canada will take appropriate action and inform Canadians as needed.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime